최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Cancers, v.12 no.4, 2020년, pp.909 -
Kwon, Ok-Seon (Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea) , Lee, Haeseung (Intellectual Information Team, Future Medicine Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea) , Kim, Yun-Jeong (College of Pharmacy, Seoul National University, Seoul 08826, Korea) , Cha, Hyuk-Jin (yunjkim36@gmail.com (Y.-J.K.)) , Song, Na-Young (hjcha93@snu.ac.kr (H.-J.C.)) , Lee, Mi-Ok (College of Pharmacy, Seoul National University, Seoul 08826, Korea)
The role of Situin 1 (SIRT1) in tumorigenesis is still controversial due to its wide range of substrates, including both oncoproteins and tumor suppressors. A recent study has demonstrated that SIRT1 interferes in the Kirsten rat sarcoma viral oncogene homolog (KRAS)-driven activation of the Raf-mit...
1. Nemoto S. Fergusson M.M. Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha} J. Biol. Chem. 2005 280 16456 16460 10.1074/jbc.M501485200 15716268
2. Lee I.H. Cao L. Mostoslavsky R. Lombard D.B. Liu J. Bruns N.E. Tsokos M. Alt F.W. Finkel T. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy Proc. Natl. Acad. Sci. USA 2008 105 3374 3379 10.1073/pnas.0712145105 18296641
3. Kim J.J. Gil N.Y. Zhang X.H. Chun K.H. Fang G. Kim J. Cho H. Jang C.Y. Cha H.J. Sirt1 Regulates microtubule dynamics through negative regulation of Plk1 in mitosis J. Cell. Biochem. 2015 116 1888 1897 10.1002/jcb.25144 25737075
4. Deng C.X. SIRT1, is it a tumor promoter or tumor suppressor? Int. J. Biol. Sci. 2009 5 147 152 10.7150/ijbs.5.147 19173036
5. Song N.Y. Surh Y.J. Janus-faced role of SIRT1 in tumorigenesis Ann. N. Y. Acad. Sci. 2012 1271 10 19 10.1111/j.1749-6632.2012.06762.x 23050959
6. Cheng H.L. Mostoslavsky R. Saito S. Manis J.P. Gu Y. Patel P. Bronson R. Appella E. Alt F.W. Chua K.F. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice Proc. Natl. Acad. Sci. USA 2003 100 10794 10799 10.1073/pnas.1934713100 12960381
7. Lee J.S. Park J.R. Kwon O.S. Lee T.H. Nakano I. Miyoshi H. Chun K.H. Park M.J. Lee H.J. Kim S.U. SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of “cancer cells with neural stemness” in a p53-dependent manner Neuro-Oncology 2015 17 95 106 10.1093/neuonc/nou145 25096191
8. Motta M.C. Divecha N. Lemieux M. Kamel C. Chen D. Gu W. Bultsma Y. McBurney M. Guarente L. Mammalian SIRT1 represses forkhead transcription factors Cell 2004 116 551 563 10.1016/S0092-8674(04)00126-6 14980222
9. Huffman D.M. Grizzle W.E. Bamman M.M. Kim J.S. Eltoum I.A. Elgavish A. Nagy T.R. SIRT1 is significantly elevated in mouse and human prostate cancer Cancer Res. 2007 67 6612 6618 10.1158/0008-5472.CAN-07-0085 17638871
10. Stunkel W. Peh B.K. Tan Y.C. Nayagam V.M. Wang X. Salto-Tellez M. Ni B. Entzeroth M. Wood J. Function of the SIRT1 protein deacetylase in cancer Biotechnol. J. 2007 2 1360 1368 10.1002/biot.200700087 17806102
11. Ford J. Jiang M. Milner J. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival Cancer Res. 2005 65 10457 10463 10.1158/0008-5472.CAN-05-1923 16288037
13. Uhl M. Csernok A. Aydin S. Kreienberg R. Wiesmuller L. Gatz S.A. Role of SIRT1 in homologous recombination DNA Repair (Amsterdam) 2010 9 383 393 10.1016/j.dnarep.2009.12.020 20097625
14. Lin Y.H. Yuan J. Pei H. Liu T. Ann D.K. Lou Z. KAP1 Deacetylation by SIRT1 promotes non-homologous end-joining repair PLoS ONE 2015 10 e0123935 10.1371/journal.pone.0123935 25905708
15. Wang R.H. Sengupta K. Li C. Kim H.S. Cao L. Xiao C. Kim S. Xu X. Zheng Y. Chilton B. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice Cancer Cell 2008 14 312 323 10.1016/j.ccr.2008.09.001 18835033
16. Costa-Machado L.F. Martin-Hernandez R. Sanchez-Luengo M.A. Hess K. Vales-Villamarin C. Barradas M. Lynch C. de la Nava D. Diaz-Ruiz A. de Cabo R. Sirt1 protects from K-Ras-driven lung carcinogenesis EMBO Rep. 2018 19 10.15252/embr.201643879
17. Pylayeva-Gupta Y. Grabocka E. Bar-Sagi D. RAS oncogenes: Weaving a tumorigenic web Nat. Rev. Cancer 2011 11 761 774 10.1038/nrc3106 21993244
18. Khalaf W.F. White H. Wenning M.J. Orazi A. Kapur R. Ingram D.A. K-Ras is essential for normal fetal liver erythropoiesis Blood 2005 105 3538 3541 10.1182/blood-2004-05-2021 15644420
19. Bos J.L. Ras oncogenes in human cancer: A review Cancer Res. 1989 49 4682 4689 2547513
20. Prior I.A. Lewis P.D. Mattos C. A comprehensive survey of Ras mutations in cancer Cancer Res. 2012 72 2457 2467 10.1158/0008-5472.CAN-11-2612 22589270
21. Hanahan D. Weinberg R.A. Hallmarks of cancer: The next generation Cell 2011 144 646 674 10.1016/j.cell.2011.02.013 21376230
22. Chambard J.C. Lefloch R. Pouyssegur J. Lenormand P. ERK implication in cell cycle regulation Biochim. Biophys. Acta 2007 1773 1299 1310 10.1016/j.bbamcr.2006.11.010 17188374
23. Braig M. Schmitt C.A. Oncogene-induced senescence: Putting the brakes on tumor development Cancer Res. 2006 66 2881 2884 10.1158/0008-5472.CAN-05-4006 16540631
24. Bulavin D.V. Fornace A.J. Jr. p38 MAP kinase’s emerging role as a tumor suppressor Adv. Cancer Res. 2004 92 95 118 10.1016/S0065-230X(04)92005-2 15530558
25. Cuenda A. Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases Biochim. Biophys. Acta 2007 1773 1358 1375 10.1016/j.bbamcr.2007.03.010 17481747
26. Westermarck J. Li S.P. Kallunki T. Han J. Kahari V.M. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression Mol. Cell. Biol. 2001 21 2373 2383 10.1128/MCB.21.7.2373-2383.2001 11259586
27. Li S.P. Junttila M.R. Han J. Kahari V.M. Westermarck J. p38 Mitogen-activated protein kinase pathway suppresses cell survival by inducing dephosphorylation of mitogen-activated protein/extracellular signal-regulated kinase kinase1,2 Cancer Res. 2003 63 3473 3477 10.1158/0008-5472.CAN-19-3320 12839928
28. Wancket L.M. Frazier W.J. Liu Y. Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease Life Sci. 2012 90 237 248 10.1016/j.lfs.2011.11.017 22197448
29. Kidger A.M. Keyse S.M. The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs) Semin. Cell Dev. Biol. 2016 50 125 132 10.1016/j.semcdb.2016.01.009 26791049
30. Shapiro P.S. Ahn N.G. Feedback regulation of Raf-1 and mitogen-activated protein kinase (MAP) kinase kinases 1 and 2 by MAP kinase phosphatase-1 (MKP-1) J. Biol. Chem. 1998 273 1788 1793 10.1074/jbc.273.3.1788 9430728
31. Sun H. Tonks N.K. Bar-Sagi D. Inhibition of Ras-induced DNA synthesis by expression of the phosphatase MKP-1 Science 1994 266 285 288 10.1126/science.7939666 7939666
32. Bang Y.J. Kwon J.H. Kang S.H. Kim J.W. Yang Y.C. Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma Biochem. Biophys. Res. Commun. 1998 250 43 47 10.1006/bbrc.1998.9256 9735328
33. Manzano R.G. Montuenga L.M. Dayton M. Dent P. Kinoshita I. Vicent S. Gardner G.J. Nguyen P. Choi Y.H. Trepel J. CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential Oncogene 2002 21 4435 4447 10.1038/sj.onc.1205542 12080474
34. Shen J. Zhang Y. Yu H. Shen B. Liang Y. Jin R. Liu X. Shi L. Cai X. Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy Cancer Med. 2016 5 2061 2068 10.1002/cam4.772 27227569
35. Wu J.J. Bennett A.M. Essential role for mitogen-activated protein (MAP) kinase phosphatase-1 in stress-responsive MAP kinase and cell survival signaling J. Biol. Chem. 2005 280 16461 16466 10.1074/jbc.M501762200 15722358
36. Moncho-Amor V. Ibanez de Caceres I. Bandres E. Martinez-Poveda B. Orgaz J.L. Sanchez-Perez I. Zazo S. Rovira A. Albanell J. Jimenez B. DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer Oncogene 2011 30 668 678 10.1038/onc.2010.449 20890299
37. Liao Q. Guo J. Kleeff J. Zimmermann A. Buchler M.W. Korc M. Friess H. Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells Gastroenterology 2003 124 1830 1845 10.1016/S0016-5085(03)00398-6 12806617
38. Vicent S. Garayoa M. Lopez-Picazo J.M. Lozano M.D. Toledo G. Thunnissen F.B. Manzano R.G. Montuenga L.M. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients Clin. Cancer Res. 2004 10 3639 3649 10.1158/1078-0432.CCR-03-0771 15173070
39. Wang H.Y. Cheng Z. Malbon C.C. Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer Cancer Lett. 2003 191 229 237 10.1016/S0304-3835(02)00612-2 12618338
40. Cao W. Bao C. Padalko E. Lowenstein C.J. Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits toll-like receptor signaling J. Exp. Med. 2008 205 1491 1503 10.1084/jem.20071728 18504304
41. Roberts P.J. Der C.J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer Oncogene 2007 26 3291 3310 10.1038/sj.onc.1210422 17496923
42. Chi H. Flavell R.A. Acetylation of MKP-1 and the control of inflammation Sci. Signal. 2008 1 pe44 10.1126/scisignal.141pe44 18922786
43. Pages G. MAP kinase phosphatase-1: A link between cell signaling and histone phosphorylation. Focus on “Histone H3 as a novel substrate for MAP kinase phosphatase-1.” Am. J. Physiol. Cell Physiol. 2009 296 C233 C234 10.1152/ajpcell.00637.2008 19109521
44. Tanoue T. Yamamoto T. Nishida E. Modular structure of a docking surface on MAPK phosphatases J. Biol. Chem. 2002 277 22942 22949 10.1074/jbc.M202096200 11953434
45. Eberharter A. Becker P.B. Histone acetylation: A switch between repressive and permissive chromatin. Second in review series on chromatin dynamics EMBO Rep. 2002 3 224 229 10.1093/embo-reports/kvf053 11882541
46. Narita T. Weinert B.T. Choudhary C. Functions and mechanisms of non-histone protein acetylation Nat. Rev. Mol. Cell Biol. 2019 20 156 174 10.1038/s41580-018-0081-3 30467427
47. Grimes M. Hall B. Foltz L. Levy T. Rikova K. Gaiser J. Cook W. Smirnova E. Wheeler T. Clark N.R. Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks Sci. Signal. 2018 11 eaaq1087 10.1126/scisignal.aaq1087 29789295
48. Sestito R. Madonna S. Scarponi C. Cianfarani F. Failla C.M. Cavani A. Girolomoni G. Albanesi C. STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation FASEB J. 2011 25 916 927 10.1096/fj.10-172288 21098725
49. Bartlett T.E. Zaikin A. Olhede S.C. West J. Teschendorff A.E. Widschwendter M. Corruption of the intra-gene DNA methylation architecture is a hallmark of cancer PLoS ONE 2013 8 e68285 10.1371/journal.pone.0068285 23874574
50. Kondoh K. Nishida E. Regulation of MAP kinases by MAP kinase phosphatases Biochim. Biophys. Acta 2007 1773 1227 1237 10.1016/j.bbamcr.2006.12.002 17208316
51. Chi H. Barry S.P. Roth R.J. Wu J.J. Jones E.A. Bennett A.M. Flavell R.A. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses Proc. Natl. Acad. Sci. USA 2006 103 2274 2279 10.1073/pnas.0510965103 16461893
52. Zhao Q. Wang X. Nelin L.D. Yao Y. Matta R. Manson M.E. Baliga R.S. Meng X. Smith C.V. Bauer J.A. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock J. Exp. Med. 2006 203 131 140 10.1084/jem.20051794 16380513
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.